Skip to content
10-Q

Quarterly Report

INTERPACE BIOSCIENCES, INC. IDXG

0001493152-26-022508

← back to feed
Filed
May 12, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 1, 2026 27.7M sh
Shares Diluted Q1 2026 · Mar 31, 2026 27.71M sh
Shares Diluted Q1 2026 · Mar 31, 2025 27.7M sh
Capex Q1 2026 · Mar 31, 2026 $141K
Operating Cash Flow Q1 2026 · Mar 31, 2026 $283K
Operating Cash Flow Q1 2026 · Mar 31, 2025 $1.24M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $2.65M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $2.51M
Stockholders Equity Q1 2026 · Mar 31, 2026 $23.08M
Stockholders Equity Q1 2026 · Dec 31, 2025 $22.36M
Stockholders Equity Q1 2026 · Mar 31, 2025 −$582K
Stockholders Equity Q1 2026 · Dec 31, 2024 −$2.22M
Current Liabilities Q1 2026 · Mar 31, 2026 $3.96M
Current Liabilities Q1 2026 · Dec 31, 2025 $5.1M
Total Liabilities Q1 2026 · Mar 31, 2026 $10.33M
Total Liabilities Q1 2026 · Dec 31, 2025 $11.48M
Current Assets Q1 2026 · Mar 31, 2026 $9.96M
Current Assets Q1 2026 · Dec 31, 2025 $9.9M
Total Assets Q1 2026 · Mar 31, 2026 $33.41M
Total Assets Q1 2026 · Dec 31, 2025 $33.84M
Eps Diluted Q1 2026 · Mar 31, 2026 $0.03
Eps Diluted Q1 2026 · Mar 31, 2025 $0.06
Eps Basic Q1 2026 · Mar 31, 2026 $0.03
Eps Basic Q1 2026 · Mar 31, 2025 $0.37
Sga Expense Q1 2026 · Mar 31, 2026 $2.45M
Sga Expense Q1 2026 · Mar 31, 2025 $2.55M
Rd Expense Q1 2026 · Mar 31, 2026 $153K
Rd Expense Q1 2026 · Mar 31, 2025 $177K
Net Income Q1 2026 · Mar 31, 2026 $721K
Net Income Q1 2026 · Mar 31, 2025 $1.65M
Operating Income Q1 2026 · Mar 31, 2026 $1.12M
Operating Income Q1 2026 · Mar 31, 2025 $1.83M
Gross Profit Q1 2026 · Mar 31, 2026 $5.9M
Gross Profit Q1 2026 · Mar 31, 2025 $7.37M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $3.13M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $4.15M
Revenue Q1 2026 · Mar 31, 2026 $9.03M
Revenue Q1 2026 · Mar 31, 2025 $11.52M